Navigating a new healthcare system is hard enough, but for immigrant women in Europe and Italy, it can create life-altering delays in cancer care. A review of current data shows that these women often face significant hurdles, including language barriers, limited knowledge about screening, and cultural beliefs that make it harder to access early detection.
Because of these obstacles, many immigrant women are diagnosed with breast cancer at much later stages than native populations. These delays can lead to more advanced disease and unequal access to the latest treatment technologies. While first-generation immigrants may initially show lower rates of breast cancer, their risk levels tend to align with local populations over time.
It is important to note that while these barriers are clear, some details remain uncertain. For example, data on specific tumor biology are limited and rarely broken down by where a person originated. Experts suggest that better policy, standard data collection, and culturally tailored education are needed to ensure every woman gets the care she needs.
